These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22508748)

  • 21. ACP Journal Club. Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years.
    Havranek EP
    Ann Intern Med; 2012 Mar; 156(6):JC3-5. PubMed ID: 22431691
    [No Abstract]   [Full Text] [Related]  

  • 22. ACP Journal Club. rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months.
    van Adel B; Oczkowski W
    Ann Intern Med; 2012 Nov; 157(10):JC5-7. PubMed ID: 23165683
    [No Abstract]   [Full Text] [Related]  

  • 23. ACP Journal Club. Glargine did not reduce CV events more than standard care in patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-10, JC3-11. PubMed ID: 22986402
    [No Abstract]   [Full Text] [Related]  

  • 24. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).
    Zhao XQ; Morse JS; Dowdy AA; Heise N; DeAngelis D; Frohlich J; Chait A; Albers JJ; Brown BG
    Am J Cardiol; 2004 Feb; 93(3):307-12. PubMed ID: 14759379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACP Journal Club. Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-11. PubMed ID: 22986403
    [No Abstract]   [Full Text] [Related]  

  • 27. ACP Journal Club. Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease.
    Farkouh ME
    Ann Intern Med; 2009 Jan; 150(2):JC1-8. PubMed ID: 19172713
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan.
    Lin TH; Voon WC; Yen HW; Huang CH; Su HM; Lai WT; Sheu SH
    Kaohsiung J Med Sci; 2006 Jun; 22(6):257-65. PubMed ID: 16793562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACP Journal Club. Review: Immediate routine lumbar-spine imaging does not improve clinical outcomes in low-back pain.
    Carey TS
    Ann Intern Med; 2009 Jun; 150(12):JC6-7. PubMed ID: 19528552
    [No Abstract]   [Full Text] [Related]  

  • 30. ACP Journal Club. Review: Aspirin does not reduce CV events but may reduce nonfatal stroke in peripheral artery disease.
    Mukherjee D
    Ann Intern Med; 2009 Sep; 151(6):JC3-5, JC3-4. PubMed ID: 19755351
    [No Abstract]   [Full Text] [Related]  

  • 31. ACP Journal Club: metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD.
    Tanner M
    Ann Intern Med; 2013 Apr; 158(8):JC4. PubMed ID: 23588769
    [No Abstract]   [Full Text] [Related]  

  • 32. ACP Journal Club. Adding procalcitonin-guided therapy to standard care did not reduce mortality in critically ill patients.
    Sacks HS
    Ann Intern Med; 2012 Feb; 156(4):JC2-06. PubMed ID: 22351732
    [No Abstract]   [Full Text] [Related]  

  • 33. ACP Journal Club. Review: Corticosteroids improve short-term outcomes but worsen longer-term outcomes in some types of tendinopathy.
    Margo KL
    Ann Intern Med; 2011 Feb; 154(4):JC2-5. PubMed ID: 21320932
    [No Abstract]   [Full Text] [Related]  

  • 34. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events.
    Krebs P; Sherman SE
    Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956
    [No Abstract]   [Full Text] [Related]  

  • 35. ACP Journal Club. Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-04, JC4-05. PubMed ID: 22508744
    [No Abstract]   [Full Text] [Related]  

  • 36. ACP Journal Club: Review: Low BP targets do not reduce mortality or CV events in hypertension.
    McAlister FA
    Ann Intern Med; 2009 Nov; 151(10):JC5-6-7. PubMed ID: 19920264
    [No Abstract]   [Full Text] [Related]  

  • 37. ACP Journal Club. The Cardiovascular Health Awareness Program reduced CV hospitalizations but not mortality in older adults.
    Elley CR; Kerse N
    Ann Intern Med; 2011 Jun; 154(12):JC6-3. PubMed ID: 21690581
    [No Abstract]   [Full Text] [Related]  

  • 38. Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders.
    Vo AN; Kashyap ML
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1303-10. PubMed ID: 19018682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACP Journal Club. Review: Addition of inhaled corticosteroids to long-acting beta2-agonists does not improve outcomes in stable COPD.
    Aaron SD
    Ann Intern Med; 2010 Mar; 152(6):JC3-5. PubMed ID: 20231559
    [No Abstract]   [Full Text] [Related]  

  • 40. ACP Journal Club. Review: statins decrease mortality and major CV events in adults with CKD not receiving dialysis.
    Ramesh Prasad GV
    Ann Intern Med; 2012 Nov; 157(10):JC5-4. PubMed ID: 23165680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.